| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Abnormal B-cell development in TIMP-deficient bone marrow
|
Weiss, Ashley
|
|
|
5 |
20 |
p. 3960-3974
|
article
|
| 2 |
Abnormalities of bone marrow B cells and plasma cells in primary immune thrombocytopenia
|
Yu, Tian-shu
|
|
|
5 |
20 |
p. 4087-4101
|
article
|
| 3 |
Activation status dictates the function of unlicensed natural killer cells in mice and humans
|
Aguilar, Ethan G.
|
|
|
5 |
20 |
p. 4219-4232
|
article
|
| 4 |
Adoptive T-cell therapy for Hodgkin lymphoma
|
Ho, Carrie
|
|
|
5 |
20 |
p. 4291-4302
|
article
|
| 5 |
Altered microbiota-host metabolic cross talk preceding neutropenic fever in patients with acute leukemia
|
Rashidi, Armin
|
|
|
5 |
20 |
p. 3937-3950
|
article
|
| 6 |
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients
|
Cuker, Adam
|
|
|
5 |
20 |
p. 3951-3959
|
article
|
| 7 |
A new murine Rpl5 (uL18) mutation provides a unique model of variably penetrant Diamond-Blackfan anemia
|
Yu, Lei
|
|
|
5 |
20 |
p. 4167-4178
|
article
|
| 8 |
A novel mechanism of thrombocytopenia by PS exposure through TMEM16F in sphingomyelin synthase 1 deficiency
|
Fujii, Yoritaka
|
|
|
5 |
20 |
p. 4265-4277
|
article
|
| 9 |
Antagonism of inhibitors of apoptosis proteins reveals a novel, immune response-based therapeutic approach for T-cell lymphoma
|
Ferrari, Nicola
|
|
|
5 |
20 |
p. 4003-4016
|
article
|
| 10 |
Anticoagulant therapy in patients with congenital FXI deficiency
|
Bravo-Pérez, Carlos
|
|
|
5 |
20 |
p. 4083-4086
|
article
|
| 11 |
A phase 1/2 study of thiotepa-based immunochemotherapy in relapsed/refractory primary CNS lymphoma: the TIER trial
|
Fox, Christopher P.
|
|
|
5 |
20 |
p. 4073-4082
|
article
|
| 12 |
A systematic review of the association between anti-β-2 glycoprotein I antibodies and APS manifestations
|
Jiang, Debbie
|
|
|
5 |
20 |
p. 3931-3936
|
article
|
| 13 |
Blood–brain barrier permeability in survivors of immune-mediated thrombotic thrombocytopenic purpura: a pilot study
|
Huang, Shih-Han Susan
|
|
|
5 |
20 |
p. 4211-4218
|
article
|
| 14 |
Blood transfusion trends in the United States: national inpatient sample, 2015 to 2018
|
Goel, Ruchika
|
|
|
5 |
20 |
p. 4179-4184
|
article
|
| 15 |
CD19-directed CAR T-cell therapy for treatment of primary CNS lymphoma
|
Siddiqi, Tanya
|
|
|
5 |
20 |
p. 4059-4063
|
article
|
| 16 |
Comparison of haploidentical and umbilical cord blood transplantation after myeloablative conditioning
|
Wagner Jr, John E.
|
|
|
5 |
20 |
p. 4064-4072
|
article
|
| 17 |
Comparison of 2-year outcomes with CAR T cells (ZUMA-1) vs salvage chemotherapy in refractory large B-cell lymphoma
|
Neelapu, Sattva S.
|
|
|
5 |
20 |
p. 4149-4155
|
article
|
| 18 |
Editorial Board
|
|
|
|
5 |
20 |
p. i
|
article
|
| 19 |
Excellent response to very-low-dose radiation (4 Gy) for indolent B-cell lymphomas: is 4 Gy suitable for curable patients?
|
Imber, Brandon S.
|
|
|
5 |
20 |
p. 4185-4197
|
article
|
| 20 |
Exogenous mitochondrial transfer and endogenous mitochondrial fission facilitate AML resistance to OxPhos inhibition
|
Saito, Kaori
|
|
|
5 |
20 |
p. 4233-4255
|
article
|
| 21 |
Follicular lymphoma and macrophages: impact of approved and novel therapies
|
Gouni, Sushanth
|
|
|
5 |
20 |
p. 4303-4312
|
article
|
| 22 |
Gata2 haploinsufficiency promotes proliferation and functional decline of hematopoietic stem cells with myeloid bias during aging
|
Abdelfattah, Ali
|
|
|
5 |
20 |
p. 4285-4290
|
article
|
| 23 |
Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutations
|
Koh, Jiwon
|
|
|
5 |
20 |
p. 3919-3930
|
article
|
| 24 |
Heterogeneous modulation of Bcl-2 family members and drug efflux mediate MCL-1 inhibitor resistance in multiple myeloma
|
Bolomsky, Arnold
|
|
|
5 |
20 |
p. 4125-4139
|
article
|
| 25 |
Improved survival of patients with aggressive ATL by increased use of allo-HCT: a prospective observational study
|
Ito, Ayumu
|
|
|
5 |
20 |
p. 4156-4166
|
article
|
| 26 |
Late-occurring venous thromboembolism in allogeneic blood or marrow transplant survivors: a BMTSS-HiGHS2 risk model
|
Gangaraju, Radhika
|
|
|
5 |
20 |
p. 4102-4111
|
article
|
| 27 |
Long-term outcome of hyper-CVAD-R for Burkitt leukemia/lymphoma and high-grade B-cell lymphoma: focus on CNS relapse
|
Samra, Bachar
|
|
|
5 |
20 |
p. 3913-3918
|
article
|
| 28 |
Multiparameter phenotyping of platelet reactivity for stratification of human cohorts
|
Dunster, Joanne L.
|
|
|
5 |
20 |
p. 4017-4030
|
article
|
| 29 |
Next-generation sequencing–based monitoring of circulating tumor DNA reveals clonotypic heterogeneity in untreated PTCL
|
Miljkovic, Milos D.
|
|
|
5 |
20 |
p. 4198-4210
|
article
|
| 30 |
Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD Consortium
|
DeFilipp, Zachariah
|
|
|
5 |
20 |
p. 4278-4284
|
article
|
| 31 |
Outcomes of patients with CLL sequentially resistant to both BCL2 and BTK inhibition
|
Lew, Thomas E.
|
|
|
5 |
20 |
p. 4054-4058
|
article
|
| 32 |
Platelet binding to polymerizing fibrin is avidity driven and requires activated αIIbβ3 but not fibrin cross-linking
|
Buitrago, Lorena
|
|
|
5 |
20 |
p. 3986-4002
|
article
|
| 33 |
Platelet variability index: a measure of platelet count fluctuations in patients with immune thrombocytopenia
|
Li, Na
|
|
|
5 |
20 |
p. 4256-4264
|
article
|
| 34 |
Population pharmacokinetic modeling of factor concentrates in hemophilia: an overview and evaluation of best practice
|
Goedhart, Tine M.H.J.
|
|
|
5 |
20 |
p. 4314-4325
|
article
|
| 35 |
Pregnancy in women with an inferior vena cava filter: a tertiary center experience and overview of the literature
|
Bistervels, Ingrid M.
|
|
|
5 |
20 |
p. 4044-4053
|
article
|
| 36 |
Therapy-related myeloid neoplasms in 109 patients after radiation monotherapy
|
Patel, Anand Ashwin
|
|
|
5 |
20 |
p. 4140-4148
|
article
|
| 37 |
TLR7 ligation augments hematopoiesis in Rps14 (uS11) deficiency via paradoxical suppression of inflammatory signaling
|
Peña, Oscar A.
|
|
|
5 |
20 |
p. 4112-4124
|
article
|
| 38 |
Transfusion of target antigens to preimmunized recipients: a new mechanism in transfusion-related acute lung injury
|
Bayat, Behnaz
|
|
|
5 |
20 |
p. 3975-3985
|
article
|
| 39 |
Treatment of allosensitized patients receiving allogeneic transplantation
|
Ciurea, Stefan O.
|
|
|
5 |
20 |
p. 4031-4043
|
article
|
| 40 |
Why is AAV FVIII gene therapy not approved by the US Food and Drug Administration yet?
|
Arruda, Valder R.
|
|
|
5 |
20 |
p. 4313
|
article
|
Journal description